An open-label study of quetiapine in anorexia nervosa
Version 2 2024-06-13, 13:55Version 2 2024-06-13, 13:55
Version 1 2020-09-04, 14:09Version 1 2020-09-04, 14:09
journal contribution
posted on 2024-06-13, 13:55 authored by P Bosanac, S Kurlender, T Norman, K Hallam, K Wesnes, T Manktelow, G BurrowsAn open-label study of quetiapine in anorexia nervosa
History
Journal
Human PsychopharmacologyVolume
22Pagination
223-230Location
EnglandISSN
0885-6222eISSN
1099-1077Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
4Publisher
JOHN WILEY & SONS LTDUsage metrics
Categories
Keywords
Science & TechnologySocial SciencesLife Sciences & BiomedicineClinical NeurologyPharmacology & PharmacyPsychiatryPsychologyNeurosciences & Neurologyanorexia nervosaquetiapineOBSESSIVE-COMPULSIVE SCALEEATING-DISORDER EXAMINATIONBULIMIA-NERVOSADEPRESSIONVALIDITYOBSESSIONALITYSCHIZOPHRENIARELIABILITYSYMPTOMSILLNESS
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC